Evonik
Leading Beyond Chemistry
Company Presentation Q3 2020
Key Messages Q3 Roadshow Season
Portfolio delivering resilience in challenging environment
Strategy execution well on track
- Acquisition of Porocel
- Announced Baby Care carveout
- Asset optimization in Methionine
Sustainability as key driver in innovation
- Next generation of ready-to-usePA12 powders for 3D printing - 80% reusability
- Biosurfactants: Evonik as key pillar in Unilever's "Clean future" initiative
Portfolio has proven resilience YTD
- Robust performance driven by growth divisions with only -1%yoy and stable pricing
- Many businesses virtually unaffected by the crisis
"Promise and deliver" - EBITDA outlook confirmed & FCF outlook increased
- EBITDA outlook now narrowed:
Range of €1.8 bn to €2.0 bn - FCF upgraded once more:
FCF ~€700 m and CCR >35%
2
Table of contents
- Evonik at a glance
- Strategy
- Financials Q3 2020
- Appendix
3
LEADING BEYOND CHEMISTRY
TO IMPROVE LIFE, TODAY AND TOMORROW
4
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Evonik Industries AG published this content on 04 November 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 November 2020 06:59:06 UTC